The Board resolution dated August 30, 2019, Cuu Long Pharmaceutical Joint Stock Corporation (DCL) approved the following issues:

1)      The Board of Directors approved to transfer the whole of 48,856,144 shares of VPC-Saigon Pharmaceutical Com Ltd (VPC-Saigon is subsidiary of DCL) in Euvipharm Pharmaceutical Joint Stock Company.

2)      The Board of Directors approved to transfer the whole of 1,000 shares in Euvipharm Pharmaceutical Joint Stock Company – member of F.I.T Group Joint Stock Company.